https://www.selleckchem.com/products/cb-5339.html
BACKGROUND AND PURPOSE Protective mechanisms of the endogenous cannabinoid (eC system against drug-induced liver injury (DILI) are actively being investigated regarding the differential regulatory role of the cannabinoid CB1 and CB2 receptors in liver fibrogenesis and inflammation. EXPERIMENTAL APPROACH The 2-arachidonoyl glycerol (2-AG)-related signaling receptors and enzymatic machinery, and inflammatory/fibrogenic factors were investigated in the liver of a mouse model of hepatotoxicity induced by acute and repeated overdoses (750
Like
Comment
Share
